Information  X 
Enter a valid email address

InnovaDerma PLC (IDP)

  Print   

Tuesday 03 March, 2020

InnovaDerma PLC

Director/PDMR Shareholding

RNS Number : 8515E
InnovaDerma PLC
03 March 2020
 

LEI: 213800WRAP6W8VDL6B38

 

InnovaDerma PLC

 ("InnovaDerma" or the "Company")

Director/PDMR Shareholding

InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life sciences products, announces, it was notified today, Joseph Bayer, Executive Chairman has purchased 16,400 Ordinary Shares of €0.10 each at a price of 58 pence per Ordinary Share (the "Purchase"). 

Following the Purchase, Joseph Bayer personally now holds a total of 49,240 shares.  He also has a separate holding of 129,000 Ordinary Shares held via his Australian Superannuation Fund which Mr Bayer controls. Therefore, Joseph Bayer's total interest in the Company through direct and indirect holdings is 178,240 Ordinary Shares representing approximately 1.23% of the issued share capital of the Company.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries

InnovaDerma

Joe Bayer

Kieran Callan c/o TB Cardew

www.innovaderma.com

 

 

 

+61 (0)3 9863 8030

+44 (0)20 7930 0777

finnCap Ltd

Geoff Nash/ Kate Bannatyne

Alice Lane/Manasa Patil - Corporate Broking

 

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser

 

+ 44 (0)20 7930 0777

[email protected]

 

 

 

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 Joseph Bayer

 

2. 

Reason for the Notification

 

a)

Position/status

Executive Chairman

 

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

InnovaDerma PLC

 

b)

LEI

213800WRAP6W8VDL6B38

 

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the Financial instrument, type of instrument

€0.10 each ("Ordinary Shares")

Identification code

IDP   GB00BT9PTW34

 

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Volume and Price - 16,400 Ordinary Shares at 58 pence per share

 

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above

 

e)

Date of the transaction

3 March 2020

 

f)

Place of the transaction

London Stock Exchange, Main Market

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHUOSRRRNUORAR

a d v e r t i s e m e n t